Emergent bacteria in cystic fibrosis: in vitro biofilm formation and resilience under variable oxygen conditions
- PMID: 24868541
- PMCID: PMC4020565
- DOI: 10.1155/2014/678301
Emergent bacteria in cystic fibrosis: in vitro biofilm formation and resilience under variable oxygen conditions
Abstract
Concurrent to conventional bacterial pathogens, unusual microbes are emerging from cystic fibrosis (CF) airways. Nonetheless, little is known about the contribution of these newly microbes to the resilience of CF-associated biofilms, particularly under variable-oxygen concentrations that are known to occur in vivo in the mucus of CF patients. Two CF-emergent bacterial species, Inquilinus limosus and Dolosigranulum pigrum, and the major pathogen Pseudomonas aeruginosa were studied in terms of biofilm development and antibiotic susceptibilities under in vitro atmospheres with different oxygen availabilities. All species were able to develop in vitro biofilms under different oxygen-available environments, with D. pigrum accumulating high amounts of biomass and respiratory activities. When established, biofilms were of difficult eradication, with antibiotics losing their effectiveness in comparison with the corresponding planktonic populations. Surprisingly, biofilms of each emergent organism displayed multidrug resistance under aerobic environments, enduring even in low-oxygen atmospheres. This study suggests a potential prospect on the impact of nonconventional organisms I. limosus and D. pigrum on CF lung infections, demonstrating capacity to adapt to biofilm mode of life under restricted-oxygen atmospheres resembling CF airways, which may ultimately endanger the efficacy of currently used antibiotic regimens.
Figures


Similar articles
-
Antibiotic resistance of mixed biofilms in cystic fibrosis: impact of emerging microorganisms on treatment of infection.Int J Antimicrob Agents. 2012 Sep;40(3):260-3. doi: 10.1016/j.ijantimicag.2012.04.020. Epub 2012 Jul 4. Int J Antimicrob Agents. 2012. PMID: 22770521
-
Developing a model for cystic fibrosis sociomicrobiology based on antibiotic and environmental stress.Int J Med Microbiol. 2017 Dec;307(8):460-470. doi: 10.1016/j.ijmm.2017.09.018. Epub 2017 Sep 28. Int J Med Microbiol. 2017. PMID: 29033313
-
Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.J Clin Microbiol. 2005 Oct;43(10):5085-90. doi: 10.1128/JCM.43.10.5085-5090.2005. J Clin Microbiol. 2005. PMID: 16207967 Free PMC article.
-
Pseudomonas aeruginosa biofilm formation in the cystic fibrosis airway.Pulm Pharmacol Ther. 2008 Aug;21(4):595-9. doi: 10.1016/j.pupt.2007.12.001. Epub 2008 Jan 29. Pulm Pharmacol Ther. 2008. PMID: 18234534 Free PMC article. Review.
-
Bugs, biofilms, and resistance in cystic fibrosis.Respir Care. 2009 May;54(5):628-40. doi: 10.4187/aarc0492. Respir Care. 2009. PMID: 19393107 Review.
Cited by
-
Nanoparticle-Mediated Strategies for Enhanced Drug Penetration and Retention in the Airway Mucosa.Pharmaceutics. 2023 Oct 13;15(10):2457. doi: 10.3390/pharmaceutics15102457. Pharmaceutics. 2023. PMID: 37896217 Free PMC article. Review.
-
Insights into Cystic Fibrosis Polymicrobial Consortia: The Role of Species Interactions in Biofilm Development, Phenotype, and Response to In-Use Antibiotics.Front Microbiol. 2017 Jan 13;7:2146. doi: 10.3389/fmicb.2016.02146. eCollection 2016. Front Microbiol. 2017. PMID: 28133457 Free PMC article.
-
Current knowledge on Inquilinus limosus, a scarcely researched human pathogen.BMC Microbiol. 2024 Nov 13;24(1):474. doi: 10.1186/s12866-024-03617-6. BMC Microbiol. 2024. PMID: 39538164 Free PMC article. Review.
-
Polymicrobial Ventilator-Associated Pneumonia: Fighting In Vitro Candida albicans-Pseudomonas aeruginosa Biofilms with Antifungal-Antibacterial Combination Therapy.PLoS One. 2017 Jan 23;12(1):e0170433. doi: 10.1371/journal.pone.0170433. eCollection 2017. PLoS One. 2017. PMID: 28114348 Free PMC article.
-
Current Status of In Vitro Models and Assays for Susceptibility Testing for Wound Biofilm Infections.Biomedicines. 2019 Apr 30;7(2):34. doi: 10.3390/biomedicines7020034. Biomedicines. 2019. PMID: 31052271 Free PMC article. Review.
References
-
- Tunney MM, Klem ER, Fodor AA, et al. Use of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosis. Thorax. 2011;66(7):579–584. - PubMed
-
- Tunney MM, Field TR, Moriarty TF, et al. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine. 2008;177(9):995–1001. - PubMed
-
- Worlitzsch D, Rintelen C, Böhm K, et al. Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients. Clinical Microbiology and Infection. 2009;15(5):454–460. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical